Verinata Health, Inc. an Illumina Company

Verinata Health, Inc. is a biotechnology company that specializes in non-invasive prenatal testing (NIPT) to enhance maternal and fetal health. As a wholly owned subsidiary of Illumina, Inc., Verinata focuses on improving prenatal care through its flagship product, the verifi® prenatal test. This test is designed for the early identification of fetal chromosomal abnormalities, particularly in high-risk pregnancies, and is known for its comprehensive screening capabilities. The verifi® test utilizes next-generation sequencing technology to analyze fetal DNA found in the mother’s blood, providing a safe and accurate alternative to invasive procedures like amniocentesis. Verinata serves a range of healthcare providers, including obstetricians, gynecologists, and maternal-fetal medicine specialists, aiming to improve pregnancy outcomes through early detection and informed decision-making. The integration with Illumina enhances Verinata's ability to deliver advanced reproductive health solutions in the genomics market.

• Employees 6
• Founded 2002